Location History:
- Toronto, CA (2015)
- North York, CA (2015 - 2022)
Company Filing History:
2 out of 77 
1 out of 12 
1 out of 51 
Years Active: 2015-2022
Title: The Innovations of Paul Van Slyke
Introduction
Paul Van Slyke is a notable inventor based in North York, Canada. He has made significant contributions to the field of biomedical research, particularly in the area of angiogenesis and antiviral treatments. With a total of four patents to his name, Van Slyke's work has the potential to impact medical therapies and improve patient outcomes.
Latest Patents
One of his latest patents is titled "Agent for promoting angiogenesis and methods and uses thereof." This patent discloses compounds that are multimeric forms of a monomeric binding peptide, which are linearly bonded to PEG moieties. These multimers are designed to stimulate angiogenesis and promote wound healing. Additionally, he has developed methods and uses of Tie2 agonists, which provide innovative approaches for treating influenza and associated bacterial superinfections. This patent also includes compositions that combine Tie2 agonists with antiviral agents, showcasing his commitment to advancing therapeutic options.
Career Highlights
Throughout his career, Paul Van Slyke has worked with esteemed organizations such as Sunnybrook Research Institute and Unity Health Toronto. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Daniel J Dumont and Warren Lee. Their collaborative efforts have further enhanced the impact of Van Slyke's inventions and research initiatives.
Conclusion
Paul Van Slyke's innovative work in the field of biomedical research exemplifies the importance of invention in advancing medical science. His patents reflect a dedication to improving health outcomes through novel therapeutic approaches.